NOD2 is reported to be a strong genetic factor associated with IBD, and USP8 can negatively regulate NOD2-induced IL-8 and IL-6 in bone marrow-derived macrophages to inhibit inflammation in IBD (65). Here, CXCL8 is linked to inflammatory bowel disease.